Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy

被引：0
|
作者：
A A Ashrani
D A Gabriel
J L Gajewski
D R Jacobs
D J Weisdorf
N S Key
机构：
[1] University of Minnesota,Department of Medicine
[2] University of North Carolina,Department of Medicine
[3] MD Anderson Cancer Center,Department of Medicine
[4] University of Minnesota,Department of Epidemiology
[5] Mayo Clinic College of Medicine,Department of Internal Medicine, Division of Hematology
[6] Fox Chase – Temple University,Bone Marrow Transplant Program
[7] University of North Carolina,Department of Medicine, Division of Hematology
来源：
Bone Marrow Transplantation | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：825 / 828
页数：3
相关论文
共 50 条
  • [21] Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
    Casasnovas, Carlos
    Ruiz, Montserrat
    Schluter, Agatha
    Naudi, Alba
    Fourcade, Stephane
    Veciana, Misericordia
    Castaner, Sara
    Alberti, Antonia
    Bargallo, Nuria
    Johnson, Maria
    Raymond, Gerald, V
    Fatemi, Ali
    Moser, Ann B.
    Villarroya, Francesc
    Portero-Otin, Manuel
    Artuch, Rafael
    Pamplona, Reinald
    Pujol, Aurora
    NEUROTHERAPEUTICS, 2019, 16 (04) : 1167 - 1182
  • [22] Efficacy and safety of sequential high-dose chemotherapy (HDCT) for relapsed or refractory germ cell cancer in a unicentric standardized approach
    Niegisch, G.
    Henn, A.
    Zaum, M.
    Kobbe, G.
    Haas, R.
    Schirren, J.
    Albers, P.
    Lorch, A.
    Oncology Research and Treatment, 2015, 38 : 86 - 86
  • [23] Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes
    M Liebl
    F Masud
    F Bostan
    E Chi
    S Pass
    K Stuebing
    Critical Care, 11 (Suppl 2):
  • [24] Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis
    Schaefers, C.
    Connolly, E. A.
    Weickhardt, A.
    Grimison, P.
    Wong, V.
    De Giorgi, U.
    Hentrich, M.
    Zschaebitz, S.
    Ochsenreither, S.
    Vincenzi, B.
    Oing, C.
    Bokemeyer, C.
    Engel, N.
    Alsdorf, W.
    Tran, B.
    ESMO OPEN, 2024, 9 (05)
  • [25] Treatment strategy for recurrent and refractory epithelial ovarian cancer: Efficacy of high-dose chemotherapy with hematopoietic stem cell transplantation
    Muramatsu, Toshinari
    Shinozuka, Takao
    Hirasawa, Takeshi
    Tsukada, Hitomi
    Maeda, Hironobu
    Miyamoto, Tsuyoshi
    Murakami, Masaru
    Kajiwara, Hiroshi
    Yasuda, Masanori
    Osamura, R. Yoshiyuki
    Mikami, Mikio
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2006, 39 (03) : 61 - 67
  • [26] Safety and efficacy of recombinant activated coagulation factor VII in congenital hemophilia with inhibitors in the home treatment setting: A review of clinical studies and registries
    Young, Guy
    Escobar, Miguel A.
    Pipe, Steven W.
    Cooper, David L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (09) : 940 - 945
  • [27] A RANDOMIZED PILOT-STUDY OF HIGH-DOSE EPIRUBICIN AS NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF CANCER OF THE BILHARZIAL BLADDER
    ELMAWLA, NG
    MANSOUR, MA
    EISSA, S
    ALI, NM
    ELATTAR, I
    HAMZA, MR
    KHALED, H
    HABBOUBI, N
    MAGRATH, I
    ELSEBAI, I
    ANNALS OF ONCOLOGY, 1991, 2 (02) : 137 - 140
  • [28] A prospective pilot study of prophylactic treatment of preterm neonates with recombinant activated factor VII during the first 72 hours of life
    Veldman, Alex
    Josef, Joerg
    Fischer, Doris
    Volk, Werner Rettwitz
    PEDIATRIC CRITICAL CARE MEDICINE, 2006, 7 (01) : 34 - 39
  • [29] Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors
    Chuansumrit, A.
    Sirachainan, N.
    Panuwannakorn, M.
    Wongwerawattanakoon, P.
    Kadegasem, P.
    Choeyprasert, W.
    Sasanakul, W.
    HAEMOPHILIA, 2013, 19 (03) : E182 - E183
  • [30] A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study
    Hoffmann, Till
    Assmann, Alexander
    Dierksen, Angelika
    Roussel, Elisabeth
    Ullrich, Sebastian
    Lichtenberg, Artur
    Albert, Alexander
    Sixt, Stephan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (04): : 1564 - +
12345